Signia GmbH

Signia GmbH specializes in hearing aids, which are medical devices designed to amplify sound for individuals with hearing loss. Their portfolio includes both behind-the-ear (BTE) models, such as the HA PURE and HA MOTION series, and in-the-ear solutions like the S_ITE SILK line. Some devices are tailored for specific needs, including unilateral hearing loss (e.g., the SET CROS PURE SPIRIT), and are available in various power levels and color options to accommodate different user requirements.

Signia GmbH is headquartered in Germany, where its hearing aids are developed and manufactured. As medical devices, these products fall under the EU’s medical device regulations. Specifically, Signia’s hearing aids are classified as Class IIa devices, which means they undergo rigorous evaluation to ensure safety and performance before entering the market. This classification aligns with their intended use in assisting hearing-impaired individuals.

Yes, Signia GmbH’s devices are registered in eudamed, the European Union’s medical device registry. This listing is mandatory for manufacturers to comply with EU medical device legislation, ensuring transparency and traceability of devices marketed within the EU. eudamed helps healthcare professionals, regulators, and patients verify the legitimacy of devices and access key information like device identification, classification, and manufacturer details.

Signia GmbH’s hearing aids are classified as Class IIa medical devices under EU regulations. This classification is determined based on the risk associated with the device’s intended use. Class IIa devices pose a moderate risk and require compliance with specific EU directives, including design controls, clinical evaluations, and conformity assessments to ensure safety and performance. This classification reflects the importance of these devices in managing hearing loss while balancing regulatory oversight.